Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
August 14, 2017
FDA Confirms That Use of mFARS as Primary Endpoint in Part 2 of the MOXIe Trial Can Support Approval of Omaveloxolone in Friedreich’s Ataxia
IRVING, Texas, Aug. 14, 2017 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced that the U.S. ...
August 14, 2017
CytoSorbents Awarded $719,000 Grant To Acutely Stabilize Severe Burn Patients
MONMOUTH JUNCTION, N.J., Aug. 14, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a leader in critical care immunotherapy specializing in blood purification, announced that it has been ...
August 14, 2017
Eiger BioPharmaceuticals Reports Second Quarter 2017 Financial Results
PALO ALTO, Calif., Aug. 14, 2017 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today ...
August 14, 2017
Lipocine Announces FDA Acknowledgement of TLANDO™ (“LPCN 1021”) NDA Resubmission; PDUFA Goal Date, February 8, 2018
SALT LAKE CITY, Aug. 14, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced that the U.S. Food & Drug Administration ...
August 14, 2017
Immune Pharmaceuticals Appoints Tony Fiorino, MD, PhD as Chief Medical Officer and Chief Operating Officer
NEW YORK -- (BUSINESS WIRE) -- Immune Pharmaceuticals (IMNP) (the “Immune” or the “Company”) announced today that it has appointed Tony Fiorino, MD, PhD to the ...
August 14, 2017
Rexahn Pharmaceuticals Issues Mid-Year Shareholder Letter to Review Recent Progress and Clinical Plans
ROCKVILLE, Md., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical-stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of ...
August 11, 2017
Alcobra Announces Second Quarter 2017 Financial Results and Provides Corporate Update
TEL AVIV, Israel, Aug. 11, 2017 (GLOBE NEWSWIRE) -- Alcobra Ltd. (ADHD) today announced financial results for the three and six months ended June 30, ...
August 11, 2017
AIT Therapeutics Reports Second Quarter 2017 Financial Results
REHOVOT, Israel and NEW YORK, Aug. 11, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage anti-microbial therapeutic company treating respiratory diseases with nitric ...
August 10, 2017
Aurinia Reports Second Quarter 2017 Financial Results, and Provides Operational Highlights
VICTORIA, British Columbia -- (BUSINESS WIRE) -- Aurinia Pharmaceuticals Inc. (AUPH) (AUP.TO) (“Aurinia” or the “Company”) has released its financial results for the second quarter ended ...
August 10, 2017
CymaBay Reports Second Quarter 2017 Financial Results and Provides Corporate Update
NEWARK, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
August 10, 2017
STRATA Skin Sciences Reports Second Quarter 2017 Financial Results
HORSHAM, Pa., Aug. 10, 2017 (GLOBE NEWSWIRE) -- (SSKN) STRATA Skin Sciences, Inc. (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to ...
August 10, 2017
TherapeuticsMD Provides TX-004HR Regulatory Update
BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women’s healthcare company, today announced a regulatory update regarding the New Drug Application (NDA) ...
August 10, 2017
SciClone Announces End Of Go-Shop Period With No Parties Designated As Excluded Parties
FOSTER CITY, Calif., Aug. 10, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (SCLN) (the "Company" or "SciClone") today announced the expiration on August 6, 2017 of ...
August 10, 2017
BioLife Solutions Announces Second Quarter 2017 Financial Results
BOTHELL, Wash., Aug. 10, 2017 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation ...
August 10, 2017
Altimmune Announces Second Quarter 2017 Financial Results and Provides Corporate Update
GAITHERSBURG, Md., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three- and six-months months ...
August 10, 2017
Basilea reports improved financial results in half-year 2017 driven by growing product sales; significant progress on partnering and development programs
Basel, Switzerland, August 10, 2017 - Basilea Pharmaceutica Ltd. (SIX:BSLN) announced today its financial results for the first half of financial year 2017 with product ...
August 10, 2017
Brainstorm to Host Second-Quarter 2017 Earnings Teleconference and Provide Important Corporate Updates, on Wednesday, August 16
HACKENSACK, N.J. and PETACH TIKVAH, Israel, Aug. 10, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative ...
August 10, 2017
Sierra Oncology Reports Second Quarter 2017 Results
VANCOUVER, Aug. 10, 2017 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response (DDR) therapeutics ...
August 10, 2017
Aradigm Announces Second Quarter 2017 Financial Results
HAYWARD, Calif. -- (BUSINESS WIRE) -- Aradigm Corporation (ARDM) (the “Company”) today announced financial results for the second quarter and six months ended June 30, 2017. ...
August 10, 2017
Zealand Pharma A/S publishes a prospectus regarding listing of 4,375,000 new shares on Nasdaq Copenhagen as part of its issue of American Depositary Shares listed on the Nasdaq in the US
Copenhagen, August 10, 2017 - With reference to company announcements (i) no. 29/2017 dated August 1, 2017 regarding launch of an initial public offering of American ...
Page 143 of 162